Supra-molecular rules in signalling networks: A single molecule comparative study in cells and tissues

Lead Research Organisation: King's College London
Department Name: Cancer Studies

Abstract

Signalling is the means by which proteins orchestrate basic intra-cellular activities and cell-to-cell communication, to regulate cell fate and to allow the development of multi-cellular organisms. To achieve a cohesive cell fate within a multi-cellular tissue, some proteins (receptors) are organised into groups at the cell surface (the plasma membrane) to function as antennas to detect extracellular chemical cues. From their position at the cell surface the receptors detect multiple inputs which they transduce across the plasma membrane to output signals in the cell interior. These signals are decoded, amplified and processed in the cell cytoplasm by intracellular signalling networks; some are subsequently transduced to the nucleus to initiate DNA transcription, replication. Then net effect is the determination of cell fate (growth, differentiation, etc.). Understanding how signal inputs and outputs are organised in protein signalling networks is one of the most fascinating questions in biology. The current dream is to derive methods that would allow the 'watching' of these network proteins in action and at atomic resolution to see details of their structure. This requires the addition of a 'time' dimension to structural biology so that the spatio-temporal parameters of all atoms in each protein can be described in detail. This is a huge challenge that in cell-free systems has begun to be partially addressed through dynamic experiments combined with molecular simulations. However, in cells, the functions of particular structural motifs are not just constraint by Brownian motions, energy landscapes and thermodynamics, but also by the local availability of partners in subcellular compartments and the boundary constraints imposed by cell environments, for example in the plasma membrane, with its 2D dimensionality, local curvature and electric fields. To understand protein function in cells observations have to be made in the only physiologically-relevant 'Laboratory', the cell. This adds many levels of complexity to an already vast challenge. Our programme of work is geared to understanding the intricate network signalling behaviour of cells in their physiological environments within tissues. We aim at describing the basic molecular ingredients, the signalling pathways and the supra-molecular structural and spatio-temporal rules regulating signalling outcomes. Our methods will be based on direct observation, 'watching' the multiple changes in the topology of interactions and its components with time, in conjunction with the modelling of behaviour at atomic resolution within a mathematical framework. Using molecular biology techniques in combination with optical methods, we can now annotate individual genes and gene products, screen for protein-protein, protein-DNA and small molecule interactions, and quantify dynamic changes. However, only single molecule-based imaging currently offers sensitive spatio-temporal detection in cells for low abundance protein interactions. This is beginning to bridge the gap between protein structure and function by allowing real-time quantitative observations of structural details, conformational intermediates, association and dissociation constants, diffusion rates, and rare events. Previous information on complex protein networks has been derived generally from high-throughput screens and/or single cell models using ensemble (averaged) technologies such as biochemical extraction followed by mass spectrometric analysis. The application of this information to understand at the molecular level the dynamic normal physiology in multi-cellular organisms and/or the pathogenetic basis of various disease states, among the heterogeneous human population is therefore limited. The approach we propose offers the means to understand and predict functional properties of cells from the changes in complex interactions between their microscopic molecular components and in response to perturbations.

Technical Summary

The proposed programme of work represents a major technological development because it employs a, thus far unavailable, pioneering technique combination that will, for the first time, provide high-resolution quantitative observations on the topology and composition of signalling complexes and the dynamics of the protein signalling network whilst at work in live cells and tissues. This will place us much closer towards a comprehensive understanding of ErbB signalling - from single molecule to the systems level. Pushing the frontiers of our understanding of signalling networks in the true physiological context requires the type of multidisciplinary approach here proposed. This will deliver in a comprehensive mathematical framework of systems modelling and prediction, integration of: wet-lab biology, several innovative optical/molecular detection techniques multidimensional single molecule microscopy, FLIM, hybrid single molecule-FLIM methods, challenging and novel data analysis algorithms, coarse-grained and molecular dynamics modelling. The methodologies to be employed are state-of-the-art and pioneering in Biology. The synergistic approach we propose will unleash the potential of each of the technologies in their application to the study of signalling networks by placing discrete groups of structure-function relationships in the context of the many thousands of possible combinatorial interactions. This is a step-change in the methods of exploitation of systems biology models because so far the only constraints available to develop systems models have arisen from putative interactions derived from high-throughput cell-free methods. Our approach is unique and will result in high-content conformational, stoichiometric, kinetic and dynamic information at the plasma membrane and the correlation with events inside the cell, being placed at the core of a mathematical systems analysis model that describes and predicts the behaviour of RTK signalling networks. Joint with BB/G006911/1

Publications

10 25 50
 
Description New methods: how to extract macromolecular structure at extreme resolution on cells (~ 6nm). New methods to measure protein orientation on cells New single molecule imaging methods. New methods of analysing single molecule data to extract kinetic and dynamic parameters. Creating a portfolio of fluorescent drugs to visualise the conformational effects of these drugs on their targets directly on cells. These developments, together with the super-resolution methods funded by BBSRC have been integrated in the Octopus facility at the Research Complex at Harwell through which they are disseminated to non experts at the earliest opportunity. Key Scientific findings: Structure of inactive and active oligomers of the Epidermal Growth Factor Receptor (EGFR) on cells at 6 nm resolution The nature of the conformational change in these oligomers that triggers signal transduction Structural determinants of EGFR oligomerisation at the plasma membrane.
Exploitation Route o The insights into in vivo mechanisms of the EGFR family have provided a framework in which others can now investigate and predict behaviour in their distinct biological contexts.
o The means by which we have been able to image and analyse patterns of behaviour at the single molecule level are available to all for analysis of other related systems.
o The way in which we have adopted our approach to the imaging of these events in model systems allows us and others to move this into direct tissue analysis.
o The understanding of receptor mechanism has opened up intervention opportunities to the medical sector.
Sectors Healthcare,Pharmaceuticals and Medical Biotechnology

URL https://www.clf.stfc.ac.uk/Pages/Octopus.aspx
 
Description The Lola programme was designed to address and model fundamental aspects of receptor function in situ. The EGFR receptor was the chosen target of investigation principally because of the importance of its roles in physiology and pathology. This prominence provided sufficient prior knowledge and capability enabling the consortium to tackle the in situ imaging that was demanded. The key publications emerging from this grant provided a series of unexpected findings for the 'real world' receptor by demonstrating: the asymmetry of the plasma membrane receptor (Tynan et al 2011), the oligomeric organisation of the signalling receptor at the plasma membrane (Needham et al 2016) and the complex higher order architecture of the basal state of the receptor (Zanetti-Dominguez et al 2018). All this was enabled by a series of imaging innovations including the development of tracking software that has just been published (Hirsch et al 2019). Beyond the EGFR receptor field itself, the methods and indeed the platforms created for single molecule imaging and data analysis for kinetic and dynamic properties, have been made available to others across a breadth of fields. This has happened through the multi user national imaging facility based at the Research Complex at Harwell (a critical member of the Lola consortium). This is a significant legacy for the BBSRC investment. To date these capabilities have been employed by Industrial collaborations as well as academics, informing on plant biology, multiple mammalian cell systems, biomaterials, bacteria, drug development, and patient biopsies. The last of the Lola impacts noted above, relates to an initiative that grew out from KCL following up on the Lola-developed capabilities. This active programme aims at addressing a hurdle in personalised medicine, which is how to predict which non-small cell lung cancer patients will benefit from a particular treatment and which of those patients will not respond. Funded by a STFC CLASP ST/S000682/1, the project is developing an automated macromolecular structure-based approach to personalised anti-cancer therapy based on novel super-resolution imaging methods developed during the LoLa project.
First Year Of Impact 2018
Sector Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Societal

 
Description Pseudokinase intervention 
Organisation AstraZeneca
Department Research and Development AstraZeneca
Country United Kingdom 
Sector Private 
PI Contribution We have screened a chemical library, counterscreened undesired chemical series, established cell based readouts for the desired property.
Collaborator Contribution AZ partners have provided the compound library. They have contributed analytical capability for the screen. Advised on compound selection. AZ have supported an FTE on this prgramme for the last year to establish mechansim of action for the lead compound(s).
Impact Chemistry, structural biology, cell and molecular biology.
Start Year 2018
 
Description Conference 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Established a working relationship with members of the TMH in Mumbai
Year(s) Of Engagement Activity 2014
 
Description Conference 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Good feedback from audience
Year(s) Of Engagement Activity 2014
URL http://smlms2013.smb.uni-frankfurt.de/
 
Description Invitation to speak 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Good audience fedback
Year(s) Of Engagement Activity 2013
 
Description Invitation to speak 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Good audience feedback
Year(s) Of Engagement Activity 2013